Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients
European Journal of Clinical Investigation · 2024-06 · 54 (6)
DOI: 10.1111/eci.14179 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 16.02.2024. Verfasst von Cheng Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Col…. Hauptthemen laut MEDLINE: Lipoprotein(a), Fibrinogen, Coronary Artery Disease, Ischemic Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National High-level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences (CIFMS).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Emerging data suggested that lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease. Previous studies indicated fibrinogen (Fib) had synergetic effect on Lp(a)‐induced events. However, combined impact of Fib and Lp(a) on ischemic stroke has not been elucidated.
Methods
In this prospective study, we consecutively enrolled 8263 patients with stable coronary artery diseases (CAD) from 2011 to 2017. Patients were categorized into three groups according to tertiles of Lp(a) levels [Lp(a)‐low, Lp(a)‐medium, and Lp(a)‐high] and further divided into nine groups by Lp(a) and Fib levels. All subjects were followed up for the occurrence of ischemic stroke.
Results
During a median follow‐up of 37.7 months, 157 (1.9%) ischemic strokes occurred. Stroke incidence increased by Lp(a) (1.1 vs. 2.1 vs. 2.5%, Cochran‐Armitage p < .001) and Fib (1.1 vs. 2.0 vs. 2.6%, Cochran‐Armitage p < .001) categories. When further classified into nine groups by Lp(a) and Fib levels, the incidence of ischemic stroke in group 9 [Lp(a)‐high and Fib‐high] was significantly higher than that in group 1 [Lp(a)‐low and Fib‐low] (3.1 vs. 6%, p < .001). The group 9 was associated with a highest risk for ischemic stroke (adjusted HR 4.907, 95% CI: 2.154–11.18, p < .001), compared with individuals in the Lp(a)‐high (adjusted HR 2.290, 95% CI: 1.483–3.537, p < .001) or Fib‐high (adjusted HR 1.184, 95% CI: 1.399–3.410, p = .001). Furthermore, combining Lp(a) with Fib increased C‐statistics by .045 ( p = .004).
Conclusions
Current study first demonstrated that elevated Lp(a) combining with Fib evaluation enhanced the risk of ischemic stroke in patients with CAD beyond Lp(a) or Fib alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiometabolic Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Cheng Yang, Jian-Jun Li
Förderung
- National High-level Hospital Clinical Research Funding
- CAMS Innovation Fund for Medical Sciences (CIFMS)
Zitieren
APA
Yang, C., Zhu, C. G., Sui, Y. G., Guo, Y. L., Wu, N. Q., Dong, Q., Xu, R. X., Qian, J., & Li, J. J. (2024). Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients. European Journal of Clinical Investigation, 54(6). https://doi.org/10.1111/eci.14179
Vancouver
Yang C, Zhu CG, Sui YG, Guo YL, Wu NQ, Dong Q, et al. Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients. European Journal of Clinical Investigation. 2024;54(6). doi:10.1111/eci.14179
BibTeX
@article{Yang2024,
author = {Yang, Cheng and Zhu, Cheng-Gang and Sui, Yong-Gang and Guo, Yuan-Lin and Wu, Na-Qiong and Dong, Qian and Xu, Rui-Xia and Qian, Jie and Li, Jian-Jun},
title = {Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients},
journal = {European Journal of Clinical Investigation},
year = {2024},
volume = {54},
number = {6},
doi = {10.1111/eci.14179}
}
EUVIMED